CAMBRIDGE, Mass., March 22, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it will be releasing its fourth quarter and full year 2015 financial results after the market close on Tuesday, March 29, 2016. The full text of the earnings release also will be available on the Company’s website at www.metabolix.com.
The Company will host a conference call on the same day at 4:30 p.m. (ET), during which senior management will provide an update on the business and answer questions from the investment community.
While shareholders participate in the call in listen-only mode, Metabolix invites shareholders to submit questions for consideration to [email protected] with the subject line: “Questions for Fourth Quarter Call.” Questions submitted in advance of the call will be reviewed and certain of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
A live webcast of the call with slides can be accessed through the “Investors” section of the Company’s website at www.metabolix.com. To participate in the call, dial toll-free (877) 709-8150 or (201) 689-8354 (international). Interested parties unable to participate in the live call may access an archived version of the webcast on the Company’s website. To listen to a telephonic replay of the conference call, dial toll-free (877) 660-6853 or (201) 612-7415 (international) and enter passcode 13630506. The replay will be available beginning at 7:30 p.m. (ET) on Tuesday, March 29, 2016 and will last through 11:59 p.m. (ET) on Monday, April 11, 2016. In addition, the webcast will be archived on the Company’s website in the investor relations section.
About Metabolix
Metabolix, Inc. is an innovation-driven specialty materials company focused on delivering high- performance biopolymer solutions to customers in the plastics industry. Metabolix’s Mirel® biopolymers, which are derived from renewable resources, are a family of biobased performance additives and specialty resins based on PHA (polyhydroxyalkanoates). Metabolix's proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction and packaging materials, as well as industrial, consumer and personal care products.
For more information, please visit www.metabolix.com. (MBLX-E)
Metabolix Contact: Lynne H. Brum, (617) 682-4693, [email protected]


Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Want to cut your energy bills? Here’s how five experts are doing it
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
John Ternus Signals Apple’s Future with Product-First AI Strategy
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 



